| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_384aadc586fc63742a49653bd3a31493 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-097 |
| filingDate |
2010-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c41545cca4a3be418577fdaf36d5f90e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3010f363bf79794f10a0003eb0ccf56f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5061acb4b03dd4a21e48f0f2b9984308 |
| publicationDate |
2011-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-101979403-A |
| titleOfInvention |
Novel cysteine aspartic acid broad-spectrum protease inhibitor and its preparation method and use |
| abstract |
The invention discloses a novel cysteine aspartic acid broad-spectrum protease inhibitor and its preparation method and application. The inhibitor has a compound represented by formula I or an optical isomer thereof. Compared with the clinical drug IDN-6556, the compound of the present invention has a lower IC50, and has a better IC50 than the animal experimental drug Q-VD-OPH, so the compound of the present invention is expected to be used in the preparation of drugs for treating hepatitis B. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102603520-A |
| priorityDate |
2010-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |